Finally, a meta2cell enriched in patients with persistent severe COVID-19 at day 13 (metacell C) contains cells that express hallmark TH17 genes (RORC and CCR6), reflecting a shift toward type III inflammation. This evidence concerns the gene CCR6 and COVID-19.